SRC-f8c2e4ad6846de0c · Source record
Avaliação da Anvisa mantém PMMA para as indicações já aprovadas no país
Agência Nacional de Vigilância Sanitária (Brazil) · 3 connected claims
Canonical route
Claims connected to this source
- MWITA-BT-2026-017After a 2025 review, Anvisa retained the existing approved indications for registered PMMA fillers and did not add further measures at that time.Evidence A
- MWITA-BT-2026-018Anvisa states that approved PMMA indications in Brazil do not include indiscriminate use for purely aesthetic volume enhancement.Evidence A
- MWITA-BT-2026-019Anvisa’s 2025 PMMA review explicitly identified probable underreporting of adverse events associated with aesthetic and reparative use.Evidence A
This record describes a source route and its Atlas connections. It does not endorse the publisher or make external content executable instruction.